Tapewire

Nasdaq · USD

PCVX

Vaxcyte, Inc.

Export transactions ↓
Tapewire entity
1164
SEC CIK
0001649094
Parsed reports
418

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202600
Feb 202600
Mar 202605
Apr 202603
May 202601
Jun 2026016
Jul 2026011
Aug 202605
Sep 202606
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 23, 2021 Filed Dec 28, 2021 21:13 UTC
GUGGENHIME ANDREWPresident and CFO
Exercise / conversionStock Option (right to buy) · Derivative 3,100 $0.00 Strike: $5.35 $0.00
Disclosure

SEC source: 0001209191-21-071374 · doc4.xml · derivative · entry 3

GUGGENHIME ANDREW · CIK 0001230724 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 518,418

Underlying: Common Stock · 3,100 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
December 23, 2021 Filed Dec 28, 2021 21:13 UTC
GUGGENHIME ANDREWPresident and CFO
SaleCommon Stock 3,100 $24.00 $74,400.00
Disclosure

SEC source: 0001209191-21-071374 · doc4.xml · nonDerivative · entry 2

GUGGENHIME ANDREW · CIK 0001230724 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 23, 2021 Filed Dec 28, 2021 21:13 UTC
GUGGENHIME ANDREWPresident and CFO
Exercise / conversionCommon Stock 3,100 $5.35 $16,585.00
Disclosure

SEC source: 0001209191-21-071374 · doc4.xml · nonDerivative · entry 1

GUGGENHIME ANDREW · CIK 0001230724 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 20, 2021 Filed Feb 8, 2022 17:27 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 4,469 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-22-007789 · doc4.xml · derivative · entry 4

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,626

Underlying: Common Stock · 4,469 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
December 20, 2021 Filed Feb 8, 2022 17:27 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 4,469 $1.79 $7,999.51
Disclosure

SEC source: 0001209191-22-007789 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2021 Filed Dec 20, 2021 16:35 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 4,619 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-070572 · doc4.xml · derivative · entry 5

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,095

Underlying: Common Stock · 4,619 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
December 16, 2021 Filed Dec 20, 2021 16:35 UTC
Fairman JeffVP, Research
SaleCommon Stock 4,619 $22.50 $103,927.50
Disclosure

SEC source: 0001209191-21-070572 · doc4.xml · nonDerivative · entry 2

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,160

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 16, 2021 Filed Dec 20, 2021 16:35 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 4,619 $1.79 $8,268.01
Disclosure

SEC source: 0001209191-21-070572 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,779

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 17:20 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 131 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-069292 · doc4.xml · derivative · entry 5

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,714

Underlying: Common Stock · 131 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 17:20 UTC
Fairman JeffVP, Research
SaleCommon Stock 131 $22.50 $2,947.50
Disclosure

SEC source: 0001209191-21-069292 · doc4.xml · nonDerivative · entry 2

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,160

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 17:20 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 131 $1.79 $234.49
Disclosure

SEC source: 0001209191-21-069292 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,291

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,016 shares acquired under the Employee Stock Purchase Plan on November 17, 2021.

Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:10 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-066539 · doc4.xml · derivative · entry 5

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,815

Underlying: Common Stock · 15,000 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:10 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 5,890 $24.00 $141,360.00
Disclosure

SEC source: 0001209191-21-066539 · doc4.xml · nonDerivative · entry 3

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,254

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $23.60 to $24.51. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:10 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 9,110 $23.09 $210,349.90
Disclosure

SEC source: 0001209191-21-066539 · doc4.xml · nonDerivative · entry 2

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 586,144

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $22.58 to $23.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:10 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionCommon Stock 15,000 $1.79 $26,850.00
Disclosure

SEC source: 0001209191-21-066539 · doc4.xml · nonDerivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 595,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 21:58 UTC
GUGGENHIME ANDREWPresident and CFO
Exercise / conversionStock Option (right to buy) · Derivative 3,100 $0.00 Strike: $5.35 $0.00
Disclosure

SEC source: 0001209191-21-066126 · doc4.xml · derivative · entry 4

GUGGENHIME ANDREW · CIK 0001230724 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 521,518

Underlying: Common Stock · 3,100 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 21:58 UTC
GUGGENHIME ANDREWPresident and CFO
SaleCommon Stock 115 $25.20 $2,898.00
Disclosure

SEC source: 0001209191-21-066126 · doc4.xml · nonDerivative · entry 3

GUGGENHIME ANDREW · CIK 0001230724 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.08 to $25.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes shares acquired under the Vaxcyte, Inc. employee stock purchase plan on November 17, 2020 of 1,562 shares and May 17, 2021 of 1,563 shares.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 21:58 UTC
GUGGENHIME ANDREWPresident and CFO
SaleCommon Stock 2,985 $24.50 $73,132.50
Disclosure

SEC source: 0001209191-21-066126 · doc4.xml · nonDerivative · entry 2

GUGGENHIME ANDREW · CIK 0001230724 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,240

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $24.04 to $24.86. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: Includes shares acquired under the Vaxcyte, Inc. employee stock purchase plan on November 17, 2020 of 1,562 shares and May 17, 2021 of 1,563 shares.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 21:58 UTC
GUGGENHIME ANDREWPresident and CFO
Exercise / conversionCommon Stock 3,100 $5.35 $16,585.00
Disclosure

SEC source: 0001209191-21-066126 · doc4.xml · nonDerivative · entry 1

GUGGENHIME ANDREW · CIK 0001230724 · President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes shares acquired under the Vaxcyte, Inc. employee stock purchase plan on November 17, 2020 of 1,562 shares and May 17, 2021 of 1,563 shares.

Read SEC document
November 08, 2021 Filed Feb 1, 2022 22:41 UTC
Dhaliwal Harpreet S.SVP Cml Mfg & Supply Chain
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $25.06 $0.00
Disclosure

SEC source: 0001209191-22-005978 · doc4.xml · derivative · entry 1

Dhaliwal Harpreet S. · CIK 0001886794 · SVP Cml Mfg & Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-11-07

F1 · derivative.exercise_date: 1/4 of the shares subject to the option shall vest on October 1, 2022, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date

Read SEC document
November 01, 2021 Filed Nov 3, 2021 17:55 UTC
Sauer PaulSVP Process Dev, Manufacturing
SaleCommon Stock 3,000 $25.00 $75,000.00
Disclosure

SEC source: 0001209191-21-062762 · doc4.xml · nonDerivative · entry 1

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,125

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
October 27, 2021 Filed Oct 29, 2021 22:11 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $22.02 $0.00
Disclosure

SEC source: 0001209191-21-062119 · doc4.xml · derivative · entry 1

Kamarck Michael E. · CIK 0001450730 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-10-26

F1 · derivative.exercise_date: Option shall vest over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date

Read SEC document
October 27, 2021 Filed Oct 29, 2021 22:12 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $22.02 $0.00
Disclosure

SEC source: 0001209191-21-062120 · doc4.xml · derivative · entry 1

Paya Carlos V · CIK 0001606244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-10-26

F1 · derivative.exercise_date: Option shall vest over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date

Read SEC document
October 26, 2021 Filed Oct 28, 2021 18:00 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 4,750 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-061940 · doc4.xml · derivative · entry 5

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,845

Underlying: Common Stock · 4,750 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 18:00 UTC
Fairman JeffVP, Research
SaleCommon Stock 4,750 $22.69 $107,777.50
Disclosure

SEC source: 0001209191-21-061940 · doc4.xml · nonDerivative · entry 2

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,144

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $22.54 to $22.855. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 18:00 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 4,750 $1.79 $8,502.50
Disclosure

SEC source: 0001209191-21-061940 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:46 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-061373 · doc4.xml · derivative · entry 5

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,815

Underlying: Common Stock · 15,000 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:46 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 1,009 $23.19 $23,398.71
Disclosure

SEC source: 0001209191-21-061373 · doc4.xml · nonDerivative · entry 3

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,254

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $23.13 to $23.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:46 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 13,991 $22.54 $315,357.14
Disclosure

SEC source: 0001209191-21-061373 · doc4.xml · nonDerivative · entry 2

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 581,263

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $22.10 to $23.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:46 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionCommon Stock 15,000 $1.79 $26,850.00
Disclosure

SEC source: 0001209191-21-061373 · doc4.xml · nonDerivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 595,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 27, 2021 Filed Sep 29, 2021 19:52 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 4,750 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-058125 · doc4.xml · derivative · entry 6

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,595

Underlying: Common Stock · 4,750 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
September 27, 2021 Filed Sep 29, 2021 19:52 UTC
Fairman JeffVP, Research
SaleCommon Stock 139 $26.47 $3,679.33
Disclosure

SEC source: 0001209191-21-058125 · doc4.xml · nonDerivative · entry 3

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,144

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
September 27, 2021 Filed Sep 29, 2021 19:52 UTC
Fairman JeffVP, Research
SaleCommon Stock 4,611 $26.16 $120,623.76
Disclosure

SEC source: 0001209191-21-058125 · doc4.xml · nonDerivative · entry 2

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,283

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.415 to $26.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 27, 2021 Filed Sep 29, 2021 19:52 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 4,750 $1.79 $8,502.50
Disclosure

SEC source: 0001209191-21-058125 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 22, 2021 Filed Sep 23, 2021 21:40 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 4,193 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-057469 · doc4.xml · derivative · entry 8

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 358,815

Underlying: Common Stock · 4,193 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
September 22, 2021 Filed Sep 23, 2021 21:40 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 4,193 $25.19 $105,635.51
Disclosure

SEC source: 0001209191-21-057469 · doc4.xml · nonDerivative · entry 5

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,254

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $24.90 to $25.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 22, 2021 Filed Sep 23, 2021 21:40 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,193 $1.79 $7,505.47
Disclosure

SEC source: 0001209191-21-057469 · doc4.xml · nonDerivative · entry 4

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 584,447

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 22, 2021 Filed Sep 24, 2021 17:04 UTC
Sauer PaulSVP Process Dev, Manufacturing
SaleCommon Stock 5,307 $25.20 $133,724.19
Disclosure

SEC source: 0001209191-21-057651 · doc4.xml · nonDerivative · entry 1

Sauer Paul · CIK 0001813796 · SVP Process Dev, Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,125

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.00 to $25.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 1,841 shares acquired under the Employee Stock Purchase Plan on May 17, 2021.

Read SEC document
September 21, 2021 Filed Sep 23, 2021 21:40 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,807 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-057469 · doc4.xml · derivative · entry 7

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 363,008

Underlying: Common Stock · 10,807 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
September 21, 2021 Filed Sep 23, 2021 21:40 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 802 $25.89 $20,763.78
Disclosure

SEC source: 0001209191-21-057469 · doc4.xml · nonDerivative · entry 3

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,254

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.88 to $25.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2021 Filed Sep 23, 2021 21:40 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 10,005 $25.17 $251,825.85
Disclosure

SEC source: 0001209191-21-057469 · doc4.xml · nonDerivative · entry 2

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 581,056

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $24.73 to $25.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2021 Filed Sep 23, 2021 21:40 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,807 $1.79 $19,344.53
Disclosure

SEC source: 0001209191-21-057469 · doc4.xml · nonDerivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 591,061

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2021 Filed Sep 21, 2021 00:01 UTC
Loxam TeriDirector
GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $26.37 $0.00
Disclosure

SEC source: 0001209191-21-056967 · doc4.xml · derivative · entry 1

Loxam Teri · CIK 0001829111 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-09-15

F1 · derivative.exercise_date: Option shall vest over 36 months, 1/3 of which will vest on September 16, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date

Read SEC document
September 16, 2021 Filed Sep 24, 2021 21:06 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $26.37 $0.00
Disclosure

SEC source: 0001209191-21-057654 · doc4.xml · derivative · entry 1

Drapeau Anne S · CIK 0001296569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-09-15

F1 · derivative.exercise_date: Option shall vest over 36 months, 1/3 of which will vest on September 16, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date

Read SEC document
August 26, 2021 Filed Aug 30, 2021 18:06 UTC
Fairman JeffVP, Research
Exercise / conversionStock Option (right to buy) · Derivative 4,750 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-053901 · doc4.xml · derivative · entry 6

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,345

Underlying: Common Stock · 4,750 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
August 26, 2021 Filed Aug 30, 2021 18:06 UTC
Fairman JeffVP, Research
SaleCommon Stock 3,218 $25.70 $82,702.60
Disclosure

SEC source: 0001209191-21-053901 · doc4.xml · nonDerivative · entry 3

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,144

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $25.06 to $26.015. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 26, 2021 Filed Aug 30, 2021 18:06 UTC
Fairman JeffVP, Research
SaleCommon Stock 1,532 $24.70 $37,840.40
Disclosure

SEC source: 0001209191-21-053901 · doc4.xml · nonDerivative · entry 2

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,362

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $24.06 to $25.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 26, 2021 Filed Aug 30, 2021 18:06 UTC
Fairman JeffVP, Research
Exercise / conversionCommon Stock 4,750 $1.79 $8,502.50
Disclosure

SEC source: 0001209191-21-053901 · doc4.xml · nonDerivative · entry 1

Fairman Jeff · CIK 0001813800 · VP, Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 23, 2021 Filed Aug 25, 2021 22:11 UTC
PICKERING GRANTDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 13,669 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0001209191-21-053357 · doc4.xml · derivative · entry 5

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,815

Underlying: Common Stock · 13,669 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
August 23, 2021 Filed Aug 25, 2021 22:11 UTC
PICKERING GRANTDirector · Chief Executive Officer
SaleCommon Stock 69 $23.10 $1,593.90
Disclosure

SEC source: 0001209191-21-053357 · doc4.xml · nonDerivative · entry 3

PICKERING GRANT · CIK 0001258693 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,254

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.